Cost-effectiveness of benmelstobart and anlotinib plus chemotherapy as first-line therapy for extensive-stage small cell lung cancer in China

C Chunyan Yan Z Zhengxiong Li J Jiayan Li Q Quan Zhao W Wenxiu Cao S Shuqing Li R Ruigang Diao

Article Details

Volume / Issue Vol. 15, Issue 1
Published March 24, 2025
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (7)

C

Chunyan Yan

Z

Zhengxiong Li

J

Jiayan Li

Q

Quan Zhao

W

Wenxiu Cao

S

Shuqing Li

R

Ruigang Diao